By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...

HealthDay News — Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a review published online ...

Both low and high levels of body roundness were linked to greater osteoarthritis risk among middle- and older-aged adults.

Patients on GLP-1s who stop taking the drugs may maintain 25% of their weight loss at one year, but whether their regained weight is mainly fat or lean mass isn’t clear.

By Dr. Liji Thomas, MD New research suggests sleeping a little longer on weekends may help people who cut their sleep short ...

Background Remission and low-disease activity are recommended targets in systemic lupus erythematosus (SLE), yet many ...

AI-enhanced optical spectroscopy revolutionizes food quality monitoring with rapid, non-destructive analysis, ensuring safety and reducing waste in production.

Background Little is known about the association between direct pollen exposure and cognitive performance. The aim of our ...

March 4, 2026 expert reaction to meta-analysis and modelling study on weight regain after stopping GLP-1 receptor agonists . A meta-analysis published in eClinicalMedicine looks a ...

A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight – but beyond this, their weight regain plateaus, with individuals managing ...

A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing ...